Cadila Healthcare Ltd Q1 2022 Earnings Call Transcript - Thomson StreetEvents

Cadila Healthcare Ltd Q1 2022 Earnings Call Transcript

Cadila Healthcare Ltd Q1 2022 Earnings Call Transcript - Thomson StreetEvents
Cadila Healthcare Ltd Q1 2022 Earnings Call Transcript
Published Aug 11, 2021
23 pages (12633 words) — Published Aug 11, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of CADI.NS earnings conference call or presentation 11-Aug-21 10:30am GMT

  
Brief Excerpt:

...Good evening, ladies and gentlemen. Welcome to our post results teleconference for the quarter ended June 2021. I do wish that you and your families are keeping safe and well. For today's call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Vishal Gor, Senior Vice President, Corporate Finance; and Mr. Alok Gur, Senior Vice President from the Managing Director's office. This quarter on, we have started the practice of sharing quarterly results, investor presentation, which we have posted on our website and filed with the stock exchange. I'm sure you would have received the same. Among our 2 key markets, India and the U.S., the contribution from the India geography has increased. This has offset some of the challenges in the U.S. during the quarter, resulting in a healthy double-digit growth in revenues and in EBITDA with an improvement in operating margins. Coming to the quarter, despite the onset of the second wave of COVID-19 in India...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Cadila Healthcare Ltd
Ticker
CADI.NS
Time
10:30am GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Ranvir Singh - Sunidhi Securities & Finance Ltd., Research Division - Analyst : Sir, on ZyCoV-D side, just to understand, are we working on any other delivery system non-invested like nasal or something?

Question: Ranvir Singh - Sunidhi Securities & Finance Ltd., Research Division - Analyst : Okay. And just for my understanding, visits and doses are different nomenclature? Or this is same?

Question: Ranvir Singh - Sunidhi Securities & Finance Ltd., Research Division - Analyst : Like we talk about 2 visits and sometimes we talk about 2 doses. So these 2 are different things or is this same?

Question: Ranvir Singh - Sunidhi Securities & Finance Ltd., Research Division - Analyst : Okay. So it is the same like having 2 doses at 2 visits. So this is the same. It is not like 1 visit may have more doses? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. AUGUST 11, 2021 / 10:30AM, CADI.NS - Q1 2022 Cadila Healthcare Ltd Earnings Call

Question: Ranvir Singh - Sunidhi Securities & Finance Ltd., Research Division - Analyst : Okay. Okay. And on U.S. generic side, the most of competition is middleman products or we see across products that competition has impacted badly?

Question: Ranvir Singh - Sunidhi Securities & Finance Ltd., Research Division - Analyst : So like Atorvastatin also we saw competition. I think that would have also impacted Q1 results right?

Question: Ranvir Singh - Sunidhi Securities & Finance Ltd., Research Division - Analyst : Okay. Okay. And last one, the related one. Like 35 product launches you are talking about and single-digit growth. So are you still -- so competition or the price erosion is likely to be deeper and going forward also? Or you see that now things are getting stabilized?

Question: Ranvir Singh - Sunidhi Securities & Finance Ltd., Research Division - Analyst : Okay. Okay. And you spoke about 30 to 35 product launches in India also in this year?

Table Of Contents

Cadila Healthcare Ltd Extraordinary Shareholders Meeting Transcript – 2022-02-18 – US$ 54.00 – Edited Transcript of CADI.NS shareholder or annual meeting 18-Feb-22 4:30am GMT

Cadila Healthcare Ltd Q3 2022 Earnings Call Transcript – 2022-02-03 – US$ 54.00 – Edited Transcript of CADI.NS earnings conference call or presentation 3-Feb-22 11:00am GMT

Cadila Healthcare Ltd Q2 2022 Earnings Call Transcript – 2021-10-29 – US$ 54.00 – Edited Transcript of CADI.NS earnings conference call or presentation 29-Oct-21 10:30am GMT

Cadila Healthcare Ltd to Discuss About the Emergency Use Authorization of ZyCov-D Vaccine Call Transcript – 2021-08-23 – US$ 54.00 – Edited Transcript of CADI.NS conference call or presentation 23-Aug-21 9:30am GMT

Cadila Healthcare Ltd Q4 2021 Earnings Call Transcript – 2021-05-27 – US$ 54.00 – Edited Transcript of CADI.NS earnings conference call or presentation 27-May-21 12:00pm GMT

Cadila Healthcare Ltd to Discuss the Transaction of Zydus Cadila Entity to Sell Its India Focused Animal Health Business to Multiples Alternate Asset Management Call Transcript – 2021-05-12 – US$ 54.00 – Edited Transcript of CADI.NS M&A conference call or presentation 12-May-21 11:00am GMT

Cadila Healthcare Ltd Q3 2021 Earnings Call Transcript – 2021-02-05 – US$ 54.00 – Edited Transcript of CADI.NS earnings conference call or presentation 5-Feb-21 11:00am GMT

Cadila Healthcare Ltd Q2 2021 Earnings Call Transcript – 2020-11-02 – US$ 54.00 – Edited Transcript of CADI.NS earnings conference call or presentation 2-Nov-20 12:45pm GMT

Cadila Healthcare Ltd Q1 2021 Earnings Call Transcript – 2020-08-05 – US$ 54.00 – Edited Transcript of CADI.NS earnings conference call or presentation 5-Aug-20 10:30am GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Cadila Healthcare Ltd Q1 2022 Earnings Call Transcript" Aug 11, 2021. Alacra Store. May 14, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2022-Cadila-Healthcare-Ltd-Earnings-Call-T14948771>
  
APA:
Thomson StreetEvents. (2021). Cadila Healthcare Ltd Q1 2022 Earnings Call Transcript Aug 11, 2021. New York, NY: Alacra Store. Retrieved May 14, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2022-Cadila-Healthcare-Ltd-Earnings-Call-T14948771>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.